If you want the garlic supplement that clinical researchers actually reach for, it is aged garlic extract (AGE), and Kyolic is the brand behind most of that literature. Wakunaga ages sliced garlic for up to 20 months, which converts the harsh, unstable allicin into stable, water-soluble S-allyl cysteine (SAC). That is the whole trick: instead of chasing a big allicin number on the label, AGE delivers a compound that survives digestion and shows up in blood. The trade-off is honesty — the best meta-analyses put the blood-pressure effect around 5 mmHg systolic in hypertensives, and the cholesterol effect is small. This is a legitimate adjunct, not a drug replacement.
Check on AmazonAffiliate link — Super Achiever Club earns a small commission at no extra cost to you.
Read the complete Garlic guide →Aged garlic extract standardized to S-allyl cysteine — a stable, water-soluble, orally bioavailable compound that survives the stomach, unlike free allicin which degrades within hours. This is the form with the strongest pharmacokinetic and clinical support.
600 mg AGE per 2-cap serving sits inside the 600–1200 mg range used in Ried's dose-response and AGE-at-Heart trials. Standardized to SAC content rather than a theoretical allicin yield, which is the more meaningful spec for this form.
Wakunaga runs its own aging and QC pipeline and the products are Non-GMO and gluten-free verified, though public batch COAs are less visible than a NSF/USP seal would provide. Long manufacturing track record offsets this.
Genuinely odorless and low-reflux because the volatile sulfur compounds are gone. Main caveat applies to all garlic: mild antiplatelet effect, so stop ~7–10 days before surgery and talk to a doctor if on warfarin/anticoagulants.
About $25 for 200 caps (100 servings) is mid-priced, but you are paying for the clinically-trialed form and a 100-day supply, so cost-per-effective-day is reasonable.
“Aged garlic extract lowers blood pressure in hypertensives”
Randomized trials by Ried et al. (Maturitas 2010; Eur J Clin Nutr 2013) using this AGE showed roughly a 5–10 mmHg systolic reduction in patients with uncontrolled hypertension versus placebo.
“It meaningfully lowers cholesterol”
Meta-analyses show only a small LDL/total-cholesterol reduction (a few mg/dL) that is inconsistent across trials; the blood-pressure effect is far better supported than the lipid effect.
“It is odorless”
The 20-month aging process converts volatile allicin-derived sulfur compounds into non-volatile SAC, so there is no garlic breath or reflux — a consistent, checkable property of AGE.
AGE deliberately has near-zero free allicin, so it loses the label-number contest to enteric allicin tablets. But allicin is unstable and poorly absorbed intact, whereas SAC is measurable in plasma — which is why AGE, not high-allicin powder, dominates the positive BP trials.
Across meta-analyses garlic delivers about a 5 mmHg systolic drop in people who are already hypertensive, and little in normotensive people. Treat it as a stackable lifestyle-tier adjunct alongside diet, sodium reduction, and exercise, not as monotherapy.
Kyolic wins because it is the form the evidence actually tested. It will not transform your lipid panel and it will not replace an antihypertensive, but as an odorless, well-tolerated daily adjunct with real (if modest) blood-pressure data behind it, nothing else in this category is better supported. Buy it if you want garlic done right.
Check Kyolic (Wakunaga) on AmazonAged garlic extract produced a dose-dependent systolic blood-pressure reduction of roughly 5–10 mmHg in patients with uncontrolled hypertension.
Pooled analysis found an average systolic reduction of about 5 mmHg in hypertensives and only modest effects on serum cholesterol.
